These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 5962711
41. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients. Mital OP, Agarwala MC, Singh SK. Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543 [No Abstract] [Full Text] [Related]
42. Cycloserine in the treatment of pulmonary tuberculosis. Aceves Ortega R, Cortés de la Peña F, Sanchez Ceceña S, Arreola Chavez C. Scand J Respir Dis Suppl; 1970 Oct; 71():109-14. PubMed ID: 5271969 [No Abstract] [Full Text] [Related]
44. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)]. Rizzo A, Magalhães M, Moura N. Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888 [No Abstract] [Full Text] [Related]
46. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis]. Kaminskaia AA, Utkin VV, Korotaev GA, Golitsina LV. Probl Tuberk; 1967 Sep; 45(5):29-33. PubMed ID: 5617941 [No Abstract] [Full Text] [Related]
47. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children. Steiner M. Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572 [No Abstract] [Full Text] [Related]
50. Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy. Ramakrishnan CV, Devadatta S, Evans C, Kamat SR, Menon NK, Radhakrishna S, Rajagopalan S, Stott H, Tripathy SP, Velu S. Tubercle; 1967 Jun; 48(2):114-27. PubMed ID: 6048655 [No Abstract] [Full Text] [Related]
51. [Use of 2d series tuberculostatic preparations for pulmonary tuberculosis patients under outpatient conditions]. Oifabakh MI, Simonian LK. Probl Tuberk; 1969 Jun; 47(11):16-20. PubMed ID: 5369220 [No Abstract] [Full Text] [Related]
52. [The treatment of urogenital tuberculosis with current drugs]. König K, May P. Urologe; 1968 Jun; 7(1):23-9. PubMed ID: 4297580 [No Abstract] [Full Text] [Related]
53. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)]. Tsukamura M. Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861 [No Abstract] [Full Text] [Related]
54. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs. Bethlem N. Scand J Respir Dis Suppl; 1970 Oct; 71():244-9. PubMed ID: 5271994 [No Abstract] [Full Text] [Related]
55. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations]. Rabukhin AE, Alekseeva VM, Ivanova ES, Kubyshkina VF, Kliuchareva EA. Probl Tuberk; 1970 Oct; 48(8):18-22. PubMed ID: 5496733 [No Abstract] [Full Text] [Related]
60. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis]. Baĭl'dinova IM. Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]